Is it safe to give birth with an activated implantable cardioverter–defibrillator: A multicentre observational study
BJOG: An International Journal of Obstetrics & Gynaecology · 2024
DOI: 10.1111/1471-0528.17777 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Willeke van der Stuijt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Heart Centre: Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, Amsterdam, The Neth…. Hauptthemen laut MEDLINE: Defibrillators, Implantable. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Data and guidelines are lacking, so implantable cardioverter–defibrillators (ICDs) are often deactivated during labour to prevent inappropriate shocks. This study aimed to ascertain the safety of an activated ICD during labour.
Design
An observational study was performed.
Setting
Dutch hospitals. Population or Sample A total of 41 childbirths were included of 26 patients who gave birth between February 2009 and November 2018 after receiving an ICD in our tertiary hospital. Five of these childbirths were attended by the research team between December 2018 and August 2020, during which the ICD remained active.
Methods
Groups were made based on ICD status during labour. Patients who gave birth with an activated ICD at least once were stratified to the activated ICD group. Patients' files were checked and patients received a questionnaire about childbirth perceptions and treatment preferences. The differences in ordinal data resulting from the questionnaire were calculated using a chi‐square or Fisher's exact test. Main outcome measures Primary outcome was inappropriate ICD therapy and occurrence of ventricular arrhythmias requiring treatment.
Results
During the 41 childbirths, no inappropriate shocks or ventricular arrhythmias occurred during labour. All patients in the activated ICD group ( n = 13) preferred this setting, while 8 of the 13 patients in the deactivated ICD group preferred activation ( p = 0.002). Reasons included avoiding hemodynamic monitoring, magnet placement, or labour induction to facilitate technician availability.
Conclusions
This study shows no evidence that labour and birth in women with an activated ICD are unsafe, as there were no ventricular arrhythmias or inappropriate therapy. In addition, most patients prefer an activated ICD during labour.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Centre: Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
- Department of Obstetrics and Gynaecology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.
- Amsterdam Reproduction and Development, Amsterdam, The Netherlands.
ORCID-Profile: Willeke van der Stuijt, Martijn A Oudijk
Zitieren
APA
van der Stuijt, W., Kooiman, K. M., de Veld, J. A., Pepplinkhuizen, S., Olde Nordkamp, L. R. A., Oudijk, M. A., Wilde, A. A. M., Smeding, L., & Knops, R. E. (2024). Is it safe to give birth with an activated implantable cardioverter–defibrillator: A multicentre observational study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17777
Vancouver
van der Stuijt W, Kooiman KM, de Veld JA, Pepplinkhuizen S, Olde Nordkamp LRA, Oudijk MA, et al. Is it safe to give birth with an activated implantable cardioverter–defibrillator: A multicentre observational study. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17777
BibTeX
@article{vanderStuijt2024,
author = {van der Stuijt, Willeke and Kooiman, Kirsten M and de Veld, Jolien A and Pepplinkhuizen, Shari and Olde Nordkamp, Louise R A and Oudijk, Martijn A and Wilde, Arthur A M and Smeding, Lonneke and Knops, Reinoud E},
title = {Is it safe to give birth with an activated implantable cardioverter–defibrillator: A multicentre observational study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
doi = {10.1111/1471-0528.17777}
}
EUVIMED